ActiveMSers Forums  

Go Back   ActiveMSers Forums > ActiveMSers.org Forums > General

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
  #1  
Old 04-24-2019, 04:56 PM
ActiveMSers's Avatar
ActiveMSers ActiveMSers is online now
Dave @ ActiveMSers
 
Join Date: Jun 2008
Location: Albuquerque, NM
Posts: 3,686
Default Which treatments improve fatigue and quality of life in MS? Researchers investigate

Journal Neurology
April 09, 2019; 92 (15 Supplement)

Which treatments improve fatigue and quality of life in Multiple Sclerosis? Evidence appraisal and development of visual interactive evidence maps (P5.2-088)
Amy Tsou, Jonathan Treadwell, Eileen Erinoff, Karen Schoelles
First published April 9, 2019,

Abstract

Objective: To determine efficacy of MS fatigue interventions and create Web-based, interactive evidence maps for the Patient Centered Outcomes Research Institute (PCORI) describing existing research, efficacy, and ongoing trials.

Background: Fatigue affects 50 to 80% of patients with multiple sclerosis (MS), with many reporting fatigue as the most troubling symptom. Despite a range of interventions, little is known regarding efficacy for fatigue (including comparative efficacy across modalities) and quality of life (QOL).

Design/Methods: We performed a systematic review and meta-analysis of MS fatigue treatments. A comprehensive literature search identified potential articles published from 1987 forward. Clinicaltrials.gov and PCORI’s website were searched to identify ongoing research. For randomized controlled trials (RCTs), we performed meta-analysis of efficacy for fatigue and QOL; adverse effect information was also extracted. Strength of evidence (SOE) was appraised using modified criteria from the AHRQ evidence-based practice system. We created 3 evidence maps using HTML, SVG and JavaScript.

Results: 282 studies met inclusion criteria. All studies (categorized by design and intervention type) were summarized in Map 1. Map 2 summarizes evidence from 45 RCTs comparing treatments to inactive control. Four interventions (aquatic exercise, combination exercise, supervised aerobic exercise, fatigue self-management) improved both fatigue and QOL. Aquatic exercise reduced fatigue the most (Hedges g=1.66, moderate SOE). Only 1 pharmacologic intervention (paroxetine) improved fatigue, but had insufficient evidence regarding QOL. Map 3 summarizes evidence from 15 RCTs comparing 2 or more active treatments. Sertraline, cognitive behavioral therapy and balance training demonstrated efficacy for fatigue (low to moderate SOE).

Conclusions: Absence of sufficient evidence for amantadine, modafinil, and methylphenidate was striking given common clinical use and potential for adverse effects. Our findings suggest increased focus on exercise and behavioral/educational interventions is warranted.

__________________
Dave Bexfield
ActiveMSers
Reply With Quote
 

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -4. The time now is 06:00 AM.


Powered by vBulletin® Version 3.7.0
Copyright ©2000 - 2019, Jelsoft Enterprises Ltd.
ActiveMSers